Herpesviral DNA packaging into nascent capsids requires multiple conserved viral 13 proteins that coordinate genome encapsidation. Here, we investigated the role of the ORF68 14 protein of Kaposi's sarcoma-associated herpesvirus (KSHV), a protein required for viral DNA 15 encapsidation whose function remains largely unresolved across the herpesviridae. We found 16 that KSHV ORF68 is expressed with early kinetics and localizes predominantly to viral replication 17 compartments, although it is dispensable for viral DNA replication and gene expression. 18
Although KSHV ORF68 has not been characterized, its homologs in alpha and 89 betaherpesviruses are expressed with late kinetics and are involved in viral DNA packaging (10, 90 13). ORF68 shares 24.8% sequence identity with UL32, its best characterized homolog from 91 HSV-1, including the five C-X-X-C motifs conserved across all the subfamily homologs (10). To 92 characterize the expression kinetics and potential functions of KSHV ORF68, we generated a 93 rabbit polyclonal antibody using recombinant ORF68 protein. We monitored the expression of 94 ORF68 in KSHV-infected iSLK.BAC16 cells, a commonly used Caki-1 cell line containing a 95 doxycycline (dox)-inducible version of the major viral lytic transactivator, ORF50 (RTA) (14, 15) . 96
Lytic reactivation of these cells upon dox treatment revealed that ORF68 expression begins as 97 early as 6 hours post-reactivation and it is robustly expressed by 18 hours (Figure 1a ). Its 98 expression kinetics mimicked those of the KSHV delayed early protein ORF59, and it was not 99 impacted by treatment with the viral DNA replication inhibitor phosphonoacetic acid (PAA), 100 which blocks expression of viral late genes such as K8.1 (Figure 1a ). Thus, KSHV ORF68 is a 101 delayed early gene. 102
ORF68 has been alternatively annotated as a 467 amino acid (aa) protein and as a 103 longer, 545 aa protein containing a 78 aa N-terminal extension (ORF68-Extended) ( Figure 1c ). 104
However, on a western blot of iSLK.BAC16 lysate, ORF68 migrated as a single band at the 105 predicted molecular weight (MW) of the 467 aa form (52kDa). To confirm that the 467 aa 106 version was the expressed form in KSHV-infected cells, we cloned both versions into a 107 mammalian expression vector and compared their migration pattern in transfected HEK293T 108 cells to endogenous ORF68 in lytically-reactivated iSLK.BAC16 cells and the KSHV-infected B cell 109 line TREx-BCBL1. Indeed, in both cell lines, only the 467 aa form of ORF68 was detected ( Figure  110 1b). 111
We next evaluated the subcellular localization of ORF68 in reactivated iSLK. BAC16 and 112 TREx-BCBL1 cells using immunofluorescence assays with the ORF68 antibody. To identify 113 infected cells, cells were co-stained with an antibody against the viral polymerase processivity 114 factor ORF59, which accumulates in viral replication compartments in the nucleus (16). We 115 observed no ORF68 staining in unreactivated or ORF59-negative cells, but in reactivated cells 116 ORF68 was present in both the cytoplasm and, more prominently, in the nucleus. In the 117 cytoplasm, it was primarily diffuse, but also localized to some randomly distributed puncta and 118 larger aggregates close to the nucleus. In the nucleus, ORF68 was localized predominantly in 119 viral replication compartments ( Figure 2) . 120 121
KSHV lacking ORF68 maintains viral DNA replication and late gene expression, but does not 122 produce infectious virions 123
To evaluate the role of ORF68 in the viral replication cycle, we generated an ORF68-124 deficient virus (ORF68 PTC ) using the BAC16 Red Recombinase system (14) by inserting two 125 premature termination codons 15 nt downstream of the translation start site. This virus was 126 used to establish a latently-infected cell line in iSLK cells. To ensure that any observed 127 phenotypes were not due to secondary mutations, we also engineered the corresponding 128 mutant rescue virus (ORF68 PTC -MR) ( Figure 3a ). Despite lacking ORF68 protein, the ORF68 PTC 129 virus expressed both the delayed early protein ORF59 and the late protein K8.1 at levels similar 130 to both the unmodified WT BAC16 KHSV and the ORF68 PTC -MR virus (Figure 3b ). Furthermore, qPCR analyses of viral DNA revealed no significant difference in DNA replication between any of 132 the viruses (Figure 3c ). We then monitored production of infectious progeny virions using a 133 supernatant transfer assay, in which the supernatant from reactivated infected iSLK cells is 134 filtered and transferred to target cells. Because the BAC16-derived KSHV contains a virally-135 encoded, constitutively-expressed GFP reporter gene, infected recipient cells can be quantified 136 by GFP expression using flow cytometry. Here, ORF68 PTC showed a marked defect, as no virus 137 production was detectable, while both WT and ORF68 PTC -MR infected cells produced sufficient 138 virus to infect nearly 100% of target cells ( Figure 3d ). Collectively, these data indicate that KSHV 139 ORF68 is essential for a late stage event in the viral replication cycle. 140
141
In the absence of ORF68, KSHV DNA is not cleaved after replication 142
The above results, together with studies of alpha and betaherpesvirus ORF68 homologs 143 (10, 13), suggested a role for KSHV ORF68 in viral DNA encapsidation. We therefore established 144 an assay similar to what has been used in other herpesviruses to measure packaging-associated 145 KSHV DNA cleavage, which occurs within the 801 bp GC-rich terminal repeat (TR) sequences 146 present in 20 -40 tandem copies in the KSHV genome (17) ( Figure 4a ). Briefly, DNA was 147 isolated from infected iSLK cells and the TR sequences were released by digesting the DNA with 148 PstI-HF, which cleaves frequently within viral (and host) DNA, but not within the KSHV TRs. This 149 should generate a ladder of TR sequences, representing the collection of individual cleavage 150 events in the TRs that occur during packaging, which can be visualized by Southern blotting 151 with a DIG-labeled TR probe. As expected, we observed a robust increase in the high MW 152
uncleaved TRs following lytic reactivation of each sample, indicative of viral genome replication 153 ( Figure 4b ). However, DNA from ORF68 PTC infected cells showed no evidence of TR cleavage, 154 unlike DNA from WT and ORF68 PTC -MR infected cells, which displayed the expected laddering 155 phenotype (Figure 4b In order to study the biochemical activity of ORF68 as it relates to DNA packaging, we 171 sought to generate pure ORF68 protein. Our attempts to isolate recombinant ORF68 from E. 172 coli bacteria, Pichia pastoris yeast, and SF9 insect cells did not yield properly folded protein 173 (data not shown). Thus, we instead purified TwinStrep-tagged ORF68 from transiently 174 transfected HEK293T cells by binding to Strep-TactinXT resin, followed by separation of ORF68 from the TwinStrep tag by PreScission protease cleavage and subsequent size exclusion 176 chromatography ( Figure 6a ). Mass spectrometry of the purified sample detected ORF68 but no 177 other contaminating proteins (data not shown). Notably, ORF68 eluted from gel filtration 178 columns as a ~275 kDa oligomer (based on injected standards) rather than as a monomer 179 ( Figure 6b ). 180
Given the failed DNA cleavage and packaging phenotypes associated with the ORF68 PTC 181 virus, we hypothesized that ORF68 might directly bind the viral genome to help direct DNA 182 packaging. We therefore used electrophoretic mobility shift assays (EMSA) to monitor binding 183 of purified ORF68 to a DNA probe containing the sequence of the KSHV TR in vitro. Indeed, 184
ORF68 efficiently bound DNA with an apparent K d of (53.34 ± 2.11) nM (Figure 7a , b). The 185 binding was cooperative, with a Hill coefficient of 1.88 ± 0.12 ( Figure 7b ). This is comparable to 186 the 72 nM K d of KSHV LANA binding to the terminal repeat (21). Multiple higher-order binding 187 events occurred at increased protein concentrations, resulting in several discrete bands of 188 protein-bound DNA (Figure 7a ). Although this in vitro DNA-binding is robust, it does not appear 189 to be specific, as similar length probes of varying GC content from disparate sources were 190 bound with similar affinity (data not shown). 191 ORF68 has no identifiable domains aside from several predicted zinc finger motifs that 192 appear to be important for the structural integrity of the protein (22). However, we noted that 193 in the presence of Mg 2+ , the TR probe or other plasmid DNA was degraded upon incubation 194 with ORF68, suggesting that it may possess nuclease activity (Figure 7c , data not shown). 195
Nuclease activity required metal ions for catalysis, with a preference for Mg 2+ or Mn 2+ , 196 drastically reduced activity with Co 2+ or Ni 2+ , and no activity with Ca 2+ or Zn 2+ (Figure 7d ).
Reactions were sensitive to EDTA or similar metal-chelating agents, consistent with our 198 observations that EDTA-containing buffers caused the precipitation of ORF68. Although our 199 mass spectrometry analysis of purified ORF68 did not detect contaminating peptides, at 200 present we cannot formally rule out the possibility that trace levels of a cellular nuclease co-201 purified with ORF68, rather than nuclease activity being an intrinsic feature of ORF68. However, 202
given that ORF68 contains putative zinc finger motifs, we reasoned that in addition to inhibition 203 by EDTA, the associated nuclease activity should be sensitive to the zinc-specific chelator 204 N,N,N′,N′-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN), which has high affinity for Zn 2+ 205 (K d = 2.6 x 10 -16 M), but very low affinity for Mg 2+ (K d = 2.6 x 10 -2 M) and other divalent cations 206 (23-25). Indeed, the addition of TPEN prevented degradation of DNA in the presence of ORF68, 207 but not DNase I, a nuclease that requires Mg 2+ for catalysis but does not contain any structural 208 zinc ( Figure 7e ). Collectively, these data demonstrate that KSHV ORF68 is a zinc finger-209 containing protein that can bind DNA and is associated with a zinc-dependent DNase activity. 210 211 Discussion 212
213
Our data firmly establish that KSHV ORF68 is essential for genome encapsidation in 214 infected cells, and further suggest novel roles for purified ORF68 protein in DNA binding and 215 cleavage. This is the first demonstration of direct DNA binding by a DNA packaging-associated 216 protein in gammaherpesviruses, and the ORF68-associated nuclease activity suggests a 217 previously unappreciated function for this protein, which may relate to viral genome processing 218 and encapsidation. Such a role would be consistent with the defects in viral TR cleavage, DNA 219 packaging, and infectious virion formation we observed in cells infected with the ORF68 PTC 220 virus. It is further supported by our TEM analysis of infected cells, which showed that in the 221 absence of ORF68, DNA encapsidation was not initiated, as evidenced by the absence of A-and 222 C-capsids. Finally, our data are in line with phenotypes observed upon deletion of the ORF68 223 homologs in HSV-1 (10), HCMV (13) and Epstein-Barr virus (EBV) (26). Indeed, in EBV, deletion 224 of this BFLF1 gene was used to generate defective viral particles for use in vaccine development 225
The ORF68 homolog in HSV-1 (UL32) was recently shown to be involved in modulation of 227 disulfide bond formation during procapsid formation, which requires the presence of the 228 conserved C-X-X-C motifs (10). Deletion of individual cysteines within four of the five motifs 229 prevented complementation of a UL32 deletion mutant virus, and in the absence of UL32 the 230 disulfide bond profiles of other viral proteins were altered. In ORF68, however, the C-X-X-C 231 motifs appear to be important for its structural integrity, as chelation of Zn 2+ causes ORF68 to 232 precipitate during purification in a manner that suggests unfolding (unpublished observations). 233
Thus, an important future challenge will be to resolve if these two functions are related, or if 234 specific roles for UL32 and ORF68 have diverged between the alpha-and gammaherpesviruses. 235
In the KSHV episome, the terminal repeats are present as 20 to 40 copies of a highly 236 repetitive ~800bp, 85% GC sequence (27). Unlike related herpesviruses, the packaging and 237 cleavage signals in the KSHV terminal repeats are unknown. However, by using a probe 238 generated from the entire repeat we could capture terminal repeats of any length. In a WT 239 KSHV infection, this yields a ladder-like cleavage pattern reflective of the fact that the genome 240 is replicated as head-to-tail concatemers, separated by an arbitrary number of terminal repeats.
While each genome should be cut only once at each end during packaging, the specific number 242 of repeats left at each genome terminus is variable (28, 29) . This is in contrast to viruses lacking 243 ORF68, which displayed WT levels of DNA replication by both qPCR and Southern blotting, but 244 no apparent resolution of the amplified concatemers into unit-length genomes. These data 245 reinforce the hypothesis that KSHV ORF68 is not required for genome replication but is integral 246 to the process of DNA encapsidation. 247
Given the stage at which ORF68 PTC virus fails during virion maturation, we hypothesized 248 that ORF68 may interact with the viral genome to promote DNA packaging. Indeed, purified 249 ORF68 robustly bound the prototypical terminal repeat subunit, with an observed K d of ~50nM. 250 This is comparable to the strength of the TR interaction for the KSHV latency-associated 251 episome tethering protein LANA, strongly suggesting that viral DNA binding is a biologically 252 relevant feature of ORF68 (21). However, it is important to note that in vitro, the DNA binding 253 activity of ORF68 does not have apparent sequence specificity. In cells, it is possible that 254 sequence specificity is conferred by other viral (or cellular) factors. Alternatively, given that 255 host DNA is largely excluded from replication compartments, sequence specific DNA binding 256 may not be required. It is also possible that the DNA binding activity participates in a distinct 257 facet of the viral lifecycle, although we did not detect any defects in the ORF68 PTC virus prior to 258 encapsidation. The ~800bp terminal repeat subunits are somewhat long for traditional EMSA 259 probes and as such, multiple binding events could be observed. Furthermore, binding of ORF68 260
to DNA was cooperative, as is frequently observed for DNA binding proteins (30). This 261 cooperativity may indicate that ORF68 binds the DNA probe at multiple sites, that the binding 262 of the first ORF68 molecule alters the DNA conformation in a way that promotes additional 263 ORF68 binding, or simply reflect our observation that ORF68 exists as an oligomer in solution. 264
In addition to DNA binding, we made the unexpected observation that in the presence 265 of the divalent cations Mg 2+ or Mn 2+ , incubation with ORF68 caused degradation of DNA. These 266 cations are commonly used by nucleases (31), and future studies are aimed at exploring 267 residues in ORF68 that could serve to coordinate divalent cations. Our robust purification 268 scheme, coupled with the absence of any detectable co-purifying peptides by mass 269 spectrometry and the fact that addition of the zinc-chelator TPEN specifically blocked ORF68-270 associated nuclease activity suggest that the activity is intrinsic to ORF68. However, aside from 271 the zinc finger motifs, no predicted domains or structural information is currently available for 272 ORF68. Thus, a key challenge will be to establish if and how ORF68 promotes DNA cleavage in 273 cells. Formal proof of nuclease activity will ultimately require structural data to identify putative 274 catalytic domain(s), which should enable isolation of point mutants to be tested for DNA 275 cleavage. Similar to the DNA binding activity, our in vitro cleavage reactions do not capture TR-276 specific targeting, as we found that other non-viral DNA was similarly susceptible to ORF68-277 associated degradation (unpublished observations). This might suggest that other components 278 of the packaging machinery are required to confer specificity or, alternatively, that the putative 279 nuclease activity is involved in an ORF68 function independent of DNA encapsidation. 280
While seven herpesviral proteins are required for proper DNA encapsidation, only two 281 have been shown to directly act on DNA. A crystal structure of a fragment of the HSV-1 UL15 282 terminase motor protein, which is homologous to KSHV ORF29, revealed that it adopts an 283 another terminase motor protein and the homolog of KSHV ORF7, has also been shown to bind 285 terminal repeat DNA in vitro (6). It has high specificity for certain terminal repeat DNA probes, 286 but only after heat treatment of the DNA, which causes them to adopt non-duplex structures 287 (6). This suggests that the UL28-DNA interaction is structure dependent, in contrast to KSHV 288 ORF68, which bound duplex DNA with no apparent sequence specificity or requirement for 289 higher order structures. Whether the UL15 and UL28 functions are conserved in their KSHV 290 homologs ORF29 and ORF7, and how KSHV ORF68 mechanistically contributes to DNA 291 encapsidation remain to be established. 292
Finally, although the majority of ORF68 is concentrated in replication compartments, the 293 protein also localizes within discrete puncta in the cytoplasm, as well as in larger aggregates 294 adjacent to the nucleus. While we hypothesize that the larger structures represent unfolded 295 protein in aggresomes, the smaller punctate structures are suggestive of a distinct function for 296 ORF68 in the cytoplasm, possibly unrelated to its role in packaging. Notably, HSV-1 UL32 was 297 also shown to localize to the cytoplasm, particularly late in infection, where it forms perinuclear 298 foci (10). Given the frequently multifunctional roles of viral proteins, it will be of interest to 299 explore possible additional cytoplasmic activities of ORF68. 
Viral mutagenesis and infection studies 325
The KSHV ORF68 Premature Termination Codon (ORF68 PTC ) mutant and corresponding 326 mutant rescue (MR) were engineered using the scarless Red recombination system in BAC16 327 GS1783 E. coli as previously described (14), except using two gBlocks (IDT) to introduce the 328 mutation. Each gBlock contained half of the kanamycin resistance cassette, as well as the 329 desired mutation, and were joined by short overlap extension PCR before being used as the 330 linear insert in the established protocol. 331
The BAC16 ORF68 mutant and MR were purified using the NucleoBond BAC 100 kit 332 (Clontech). iSLK cell lines latently infected with the KSHV ORF68 PTC virus were then established 333 by co-culture of the relevant BAC16-containing HEK293T cells with uninfected target iSLK-Puro 334 cells. HEK293T cells constitutively expressing ORF68 (HEK293T-ORF68) were transfected with 12 335 µg of BAC16 containing ORF68 PTC or MR using linear polyethylenimine (PEI, MW ~25,000) at a 336 1:3 DNA:PEI ratio. The following day, the cells were trypsinized and mixed 1:1 with iSLK-puro 337 cells, then treated with 30 nM 12-O-Tetradecanoylphorbol-13-acetate (TPA) and 300 nM 338 sodium butyrate for 4 days to induce lytic replication. Cells were then incubated with selection 339 media containing 300 µg/ml hygromycin B, 1 µg/ml puromycin, and 250 µg/ml G418. Media 340 was replaced every other day for ~2 weeks, gradually increasing the hygromycin B 341 concentration to 1 mg/ml until there were no HEK293T cells remaining and the iSLK cells were 342 green and replicating. 343
For induction studies, BAC16-containing iSLK cells were treated with 1 µg/ml doxycycline 344 and 1 mM sodium butyrate, and TREx-BCBL1 cells were induced with doxycycline (1 ug/ml) and 345 TPA (25 ng/ml) for the indicated amount of time. Virion production from reactivated iSLK cells 346 was measured using supernatant transfer assays at 72 hours post induction. The supernatant 347 was filtered through a 0.45 µM PES filter, then 2 ml were mixed with 1x10 6 freshly trypsinized 348
HEK293T cells. The cell mixture was placed into a 6 well plate and centrifuged at 1,200 x g for 2 349 hours at 32˚C. The following day, cells were trypsinized, fixed in 4% paraformaldehyde, then were isolated by first collecting antibodies that bound an MBP-ORF68 column, followed by 379 removal of non-specific antibodies on an MBP column. Both selection columns were generated 380 using the AminoLink Plus Immobilization Kit (ThermoFisher). 381 382
Immunofluorescence assays 383
Cells were fixed with 4% paraformaldehyde, permeabilized with ice-cold methanol at -384 20˚C for 20 min, then blocked with BSA blocking buffer (PBS, 1% Triton X-100, 0.5% Tween20, 385 3% BSA) for 30 minutes at room temperature. They were then incubated with rabbit anti-ORF68 386 and mouse anti-ORF59 (Advanced Biotechnologies) antibodies (diluted 1:100 in blocking buffer) 387 overnight at 4˚C, washed with PBS, and incubated with secondary antibody (AlexaFluor594 or 388 DyLight650, 1:1000 in BSA blocking buffer) for 1 h at 37˚C, and mounted using VectaShield 389
HardSet with DAPI (ThermoFisher). Images were acquired on an EVOS FL inverted fluorescent 390 microscope (ThermoFisher). 391 392 DNA isolation and qPCR 393 iSLK-BAC16 cells were incubated with 5x proteinase K digestion buffer (50 mM Tris-HCl 394 pH 7.4, 500 mM NaCl, 5 mM EDTA, 2.5% SDS) and digested with proteinase K (80 µg/ml) 395 overnight at 55˚C. The gDNA was isolated using Zymo Quick gDNA Miniprep Kit according to the 396 manufacturer's instructions. 397
Quantitative PCR was performed on the isolated DNA using iTaq Universal SYBR Green 398 Supermix on a QuantStudio3 Real-Time PCR machine. DNA levels were quantified using relative 399 standard curves with primers specific for KSHV ORF57 (5'-GGTGTGTCTGACGCCGTAAAG-3' and 400 5'-CCTGTCCGTAAACACCTCCG-3') or a region in the GAPDH promoter (5'-401 TACTAGCGGTTTTACGGGCG-3' and 5'-TCGAACAGGAGGAGCAGAGAGCGA-3'). The relative 402 genome numbers were normalized to GAPDH to account for loading differences and to 403 uninduced samples to account for starting genome copy number. 404 405
Protein purification 406
TwinStrep-PreScission-ORF68 was transfected using PEI into 50 90% confluent 15 cm 407 plates of HEK293T cells for 48h. Cells were lysed in 5 ml of lysis buffer (100 mM Tris-HCl pH 8.0, 408 300 mM NaCl, 1 mM DTT, 5% glycerol, 0.1% CHAPS, 1 µg/ml avidin, cOmplete EDTA-free 409 protease inhibitors [Sigma-Aldrich]) per 1 g of cell pellet and rotated at 4˚C for an additional 30 410 minutes. The viscosity was reduced by sonication, whereupon debris was removed by 411 centrifugation at 20,000 x g (4˚C) for 30 min followed by filtration through a 0.45 µm PES filter 412 with a glass pre-filter (Millipore). Lysate was passed three times over a gravity column 413 containing Strep-Tactin XT Superflow slurry (IBA) then washed with 5 column volumes of strep 414 running buffer (100 mM Tris-HCl pH 8.0, 300 mM NaCl, 1 mM DTT, 5% glycerol, 0.1% CHAPS). and was degassed thoroughly before polymerization. Following the electrophoresis, the gel was 444 removed from the running cassette and stained with SYBRgold (ThermoFisher) in 0.5X TB for 30 445 minutes, rocking at room temperature and protected from light. Staining solution was removed 446 by briefly washing with fresh 0.5X TB and the gel was imaged on a ChemiDoc Touch (Bio-rad). 447
All bands were quantified using ImageLab v6.0 (Bio-rad) and percent bound probe was 448 determined by dividing shifted band intensity by the total intensity of all bands in that lane. 449
Binding curves were generated using Prism v7 (GraphPad) by non-linear regression fit using 450 least-squares. Shown data represents three technical replicates performed on different days. 451 452
Nuclease assays 453
The EMSA probe was also used for nuclease assays and was produced as described 454 above. Reactions were assembled in nuclease buffer (25 mM HEPES pH 7.6, 50 mM NaCl, 50 455 mM KCl, 0.1 mg/ml BSA, 2.5 mM MgCl 2 ) with 1 nM DNA probe and 2-fold dilutions of ORF68 456 ranging from 9.77 to 5000 nM. The reactions were incubated at 37˚C overnight. iSLK.BAC16 WT or ORF68 PTC -infected cells were induced for 48 hours as described 491 above. Cells were washed once with PBS and fixed with 2% glutaraldehyde, 4% 492 paraformaldehyde in 100 mM sodium cacodylate buffer, pH 7.2 for 10 minutes at room 493 temperature. Fixative was removed and cells were scraped into 2% glutaraldehyde in 100 mM 494 sodium cacodylate buffer, pH 7.2 and evenly resuspended by pipetting. Cells were then washed 495 with 1% osmium tetroxide, 0.8% ferricyanide in 100 mM sodium cacodylate buffer, pH 7.2, 496 before being treated with 1% uranyl acetate and dehydrated with increasing concentrations of 497 acetone. Samples were then infiltrated and embedded in resin, from which 70 nm sections 498 were cut on a Reichert-Jung microtome. Sections were picked up on copper mesh grids coated 499 with 0.5% formvar, post-stained with uranyl acetate and lead citrate, and examined using an FEI 500
Tecnai 12 transmission electron microscope. 501 
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